A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
407
Participants
Timeline
Start Date
September 30, 2003
Study Completion Date
March 31, 2005
Conditions
ObesityBinge-Eating Disorder
Interventions
DRUG
topiramate
All Listed Sponsors
collaborator
Ortho-McNeil Neurologics, Inc.
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00210808 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity | Biotech Hunter | Biotech Hunter